Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases
Roger Bate, scholar at the American Enterprise Institute

“…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance is rising and controlling such strains is vital. We need better management of existing treatments and the careful deployment of new ones. Rather than complain about drug prices, governments should help developing countries reform their drug approval regulations and strengthen distribution channels so proven drugs get to patients quickly and safely” (6/4).